These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26392569)

  • 1. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
    Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
    Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
    Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
    J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
    Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
    J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
    Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
    Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
    Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
    Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
    Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
    Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
    Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
    Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
    J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
    Juilland M; Thome M
    Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination for activation: new directions in the NF-kappaB roadmap.
    Lynch OT; Gadina M
    Mol Interv; 2004 Jun; 4(3):144-6. PubMed ID: 15210867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
    Fontán L; Melnick A
    Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
    Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
    Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
    Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
    J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.
    McAllister-Lucas LM; Jin X; Gu S; Siu K; McDonnell S; Ruland J; Delekta PC; Van Beek M; Lucas PC
    J Biol Chem; 2010 Aug; 285(34):25880-4. PubMed ID: 20605784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
    Rehman AO; Wang CY
    Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.
    Borthakur A; Bhattacharyya S; Alrefai WA; Tobacman JK; Ramaswamy K; Dudeja PK
    Inflamm Bowel Dis; 2010 Apr; 16(4):593-603. PubMed ID: 19714753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.
    Schimmack G; Eitelhuber AC; Vincendeau M; Demski K; Shinohara H; Kurosaki T; Krappmann D
    Cell Commun Signal; 2014 Jul; 12():49. PubMed ID: 25245034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.